Automotive, Healthcare Nov 26, 2021 09:18 AM (GMT+8) · EqualOcean
The National Medical Insurance Bureau conducted the Sixth Batch of centralized drug procurement organized by the state in Shanghai. This is a special procurement of insulin. According to the demand proposed by 32000 medical institutions, the demand for centralized insulin collection is about 200 million, involving an amount of about 17 billion yuan, which is related to the well-being of 10 million insulin users in China. This morning, the bidding and bid opening of insulin production enterprises will be carried out, and the winning results will be announced later. Different from the previous five centralized purchases, insulin belongs to biological drugs, which indicates that the scope of centralized drug procurement organized by the state has expanded from chemical drugs to biological drugs, which will further reduce the drug burden of patients.